Filing Details
- Accession Number:
- 0001209191-17-042160
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-28 17:05:59
- Reporting Period:
- 2017-06-22
- Filing Date:
- 2017-06-28
- Accepted Time:
- 2017-06-28 17:05:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590560 | Uniqure N.v. | QURE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1693830 | Harald Petry | C/O Uniqure N.v. Paasheuvelweg 25A Amsterdam P7 1105 BP | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2017-06-22 | 155 | $3.42 | 155 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2017-06-22 | 155 | $6.00 | 0 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2017-06-26 | 58,075 | $3.43 | 58,075 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2017-06-26 | 58,075 | $6.01 | 0 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2017-06-27 | 7,700 | $3.48 | 7,700 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2017-06-27 | 7,700 | $6.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2017-06-22 | 155 | $0.00 | 155 | $3.42 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2017-06-26 | 58,075 | $0.00 | 58,075 | $3.43 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2017-06-27 | 7,700 | $0.00 | 7,700 | $3.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 115,075 | 2022-04-05 | No | 4 | M | Direct | |
| 57,000 | 2022-04-05 | No | 4 | M | Direct | |
| 49,300 | 2022-04-05 | No | 4 | M | Direct |
Footnotes
- The stock option was exercised at a price of 3.07 Euros per share. The conversion from Euro to U.S. dollars ($) applied the exchange rate of 1.1151 Euros to U.S. dollars as of the exercise date.
- The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017.
- The stock option was exercised at a price of 3.07 Euros per share. The conversion from Euro to U.S. dollars ($) applied the exchange rate of 1.1182 Euros to U.S. dollars as of the exercise date.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.13, inclusive. The reporting person undertakes to provide to uniQure N.V., any security holder of uniQure N.V. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price ranges set forth in this footnote.
- The stock option was exercised at a price of 3.07 Euros per share. The conversion from Euro to U.S. dollars ($) applied the exchange rate of 1.1339 Euros to U.S. dollars as of the exercise date.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from from $6.00 to $6.02, inclusive. The reporting person undertakes to provide to uniQure N.V., any security holder of uniQure N.V. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price ranges set forth in this footnote.
- The Stock Option vested in full on February 6, 2014.
Billionaire Hedge Funds
